Hypofractionation and concomitant boost to deliver adjuvant whole-breast radiation in ductal carcinoma in situ (DCIS): a subgroup analysis of a prospective case series
- 12 January 2014
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 31 (2) , 838
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trialsThe Lancet Oncology, 2013
- Intensity-modulated adjuvant whole breast radiation delivered with static angle tomotherapy (TomoDirect): a prospective case seriesJournal of Cancer Research and Clinical Oncology, 2013
- Two different hypofractionated breast radiotherapy schedules for 113 patients with ductal carcinoma in situ: preliminary results.2013
- Does TomoDirect 3DCRT represent a suitable option for post-operative whole breast irradiation? A hypothesis-generating pilot studyRadiation Oncology, 2012
- Risk Stratification in Ductal Carcinoma in Situ: The Role of Genomic TestingCurrent Oncology Reports, 2012
- Five Year Outcome of 145 Patients With Ductal Carcinoma In Situ (DCIS) After Accelerated Breast RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Fractionation for Whole Breast Irradiation: An American Society for Radiation Oncology (ASTRO) Evidence-Based GuidelineInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Shorter fractionation schedules in breast cancer radiotherapy: Clinical and economic implicationsEuropean Journal of Cancer, 2009
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.Journal of Clinical Oncology, 1998